Lifevantage Corporation (NASDAQ:LFVN - Get Free Report) Director Michael Beindorff sold 10,000 shares of the company's stock in a transaction that occurred on Thursday, November 12th. The shares were sold at an average price of $4.89, for a total transaction of $48,900.00. Following the transaction, the director owned 31,625 shares in the company, valued at $154,646.25. The trade was a 24.02% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
Lifevantage Trading Down 4.0%
Shares of NASDAQ LFVN traded down $0.20 during midday trading on Monday, reaching $4.77. The company had a trading volume of 118,381 shares, compared to its average volume of 213,491. Lifevantage Corporation has a 1 year low of $3.90 and a 1 year high of $11.71. The business's 50-day simple moving average is $5.93 and its 200 day simple moving average is $5.86. The stock has a market cap of $60.49 million, a P/E ratio of 22.72 and a beta of 0.71.
Lifevantage (NASDAQ:LFVN - Get Free Report) last announced its quarterly earnings data on Monday, November 9th. The company reported $0.05 earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by ($0.01). Lifevantage had a net margin of 1.58% and a return on equity of 16.35%. The company had revenue of $37.12 million for the quarter, compared to analysts' expectations of $40.49 million.
Lifevantage Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Tuesday, December 1st will be given a dividend of $0.05 per share. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $0.20 dividend on an annualized basis and a yield of 4.2%. Lifevantage's payout ratio is currently 95.24%.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Hsbc Holdings PLC acquired a new stake in Lifevantage during the 1st quarter worth about $51,000. Bank of New York Mellon Corp acquired a new position in shares of Lifevantage in the 2nd quarter valued at about $78,000. Bank of America Corp DE boosted its stake in shares of Lifevantage by 24.3% in the first quarter. Bank of America Corp DE now owns 23,445 shares of the company's stock worth $101,000 after buying an additional 4,586 shares during the last quarter. Finally, Engineers Gate Manager LP boosted its stake in shares of Lifevantage by 109.7% in the second quarter. Engineers Gate Manager LP now owns 27,009 shares of the company's stock worth $169,000 after buying an additional 14,131 shares during the last quarter. 35.32% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several analysts have weighed in on LFVN shares. Freedom Broker dropped their price target on Lifevantage from $9.00 to $8.00 and set a "buy" rating on the stock in a research note on Friday. Zacks Research cut Lifevantage from a "hold" rating to a "strong sell" rating in a research note on Friday, October 16th. Lake Street Capital raised their price objective on Lifevantage from $5.00 to $6.00 and gave the stock a "hold" rating in a research note on Friday, August 28th. UBS Group set a $8.00 target price on Lifevantage in a report on Friday. Finally, Weiss Ratings lowered Lifevantage from a "hold (c)" rating to a "hold (c-)" rating in a research report on Friday. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $6.75.
Get Our Latest Report on Lifevantage
About Lifevantage
(
Get Free Report)
LifeVantage Corporation is a health and wellness company that develops and sells dietary supplements, skincare products and other wellness offerings. Its product range includes Protandim supplements and the TrueScience skincare line, with products marketed around the company's focus on nutrigenomics—the study of how nutrition interacts with gene expression. Founded in 2003, LifeVantage primarily sells through independent consultants and online channels. The company serves customers in markets across North America, Europe and the Asia-Pacific region.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lifevantage, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lifevantage wasn't on the list.
While Lifevantage currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.